We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00066625
Recruitment Status : Terminated (Administratively complete.)
First Posted : August 7, 2003
Last Update Posted : February 1, 2013
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 2007
  Study Completion Date : No date given